Clinical Trial Update: Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating intranasal nalmefene in healthy volunteers, with relevance to opioid-related disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Nalmefene (nalmefene)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid-Related Disorders | Phase 1 | Status: COMPLETED